Malaria vaccine in India: need and choice

Rajaram Saranya; Chandar Sahanaa; Roselin Mohandass

doi:10.18203/2394-6040.ijcmph20223246

Authors

Rajaram Saranya Department of Community Medicine, Pondicherry Institute of Medicine Sciences, Pondicherry, India
Chandar Sahanaa Department of Community Medicine, Pondicherry Institute of Medicine Sciences, Pondicherry, India http://orcid.org/0000-0001-8355-0056
Roselin Mohandass Department of Community Medicine, Pondicherry Institute of Medicine Sciences, Pondicherry, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20223246

Keywords:

Malaria, Vaccines, RTS, S/AS01

Abstract

Malaria is a major public health problem in India. India’s varied geography and diverse climatic conditions from tropical monsoon in the south to temperate in the north, favor the distribution of vectors and species of the malaria parasite. Malaria in India takes several forms, including forest/ tribal malaria, urban malaria, industrial malaria, and plains malaria. P. falciparum and P vivax species contribute to the majority of malarial cases and deaths in India.

Metrics

Metrics Loading ...

Author Biographies

Rajaram Saranya, Department of Community Medicine, Pondicherry Institute of Medicine Sciences, Pondicherry, India

Department of Community Medicine

Assistant Professor

Chandar Sahanaa, Department of Community Medicine, Pondicherry Institute of Medicine Sciences, Pondicherry, India

Department of Community Medicine

Assistant Professor

Roselin Mohandass, Department of Community Medicine, Pondicherry Institute of Medicine Sciences, Pondicherry, India

Department of Community Medicine

Assistant Professor

References

World Health Organization. World malaria report 2020. Geneva (Switzerland): World Health Organization; 2020. Available at: http://www.who.int/publications/i/item/9789240015791. Accessed on 20 January 2022.

Global technical strategy for malaria 2016-2030; Geneva (Switzerland): World Health Organization. 2015. Available at: http://www.who.int/ publications/i/item/9789240031357. Accessed on 20 January 2022.

MVI Path Malaria Vaccine Initiative. Accelerating Malaria Vaccine Development. Available at: https://www.malariavaccine.org. Accessed 05 October 2022.

Laurens MB. Novel malaria vaccines. Hum Vaccin Immunother. 2021;17(11):4549-52.

Laurens MB. RTS, S/AS01 vaccine (Mosquirix™): an overview. Hum Vaccin Immunother. 2020;16(3):480-9.

MVI Path Malaria Vaccine Initiative. R & D RTS, S. Available at: http://www.malariavaccine.org/ pr_2011_pfs25.php. Accessed on 20 January 2022.

Clinical Trials Partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):30.